HSBC Holdings’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$347K Buy
+17,579
New +$347K ﹤0.01% 1899
2025
Q1
Sell
-9,292
Closed -$233K 2594
2024
Q4
$233K Buy
+9,292
New +$233K ﹤0.01% 2219
2017
Q1
Sell
-1,097
Closed -$58K 1754
2016
Q4
$58K Buy
+1,097
New +$58K ﹤0.01% 2208